Wednesday, January 14, 2004 2:37:33 AM
First I would split DNAP into two companies, one would have DNAWitness and Ancestry (maybe they could put this in CMIH) and the other would have all the medical products they are working on. I would then merge the medical side with a small drug company.
XKEM is sitting out there with problems, but they have a cancer fighting drug paclitaxel and another in the pipeline for sickle cell leukemia. The following link shows some of its promise.
http://ragingbull.lycos.com/mboard/boards.cgi?board=XKEM&read=1360
On the down side of this is that XKEM has been a bigger disappointment then DNAP.
Jim
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM